BofA lowered the firm’s price target on Harmony Biosciences (HRMY) to $32 from $33 and keeps an Underperform rating on the shares. The firm, in its preview of Q1 EPS updates for its commercial ...

"I don't think movies are going away," the "Baby Invasion" director told IndieWire at the Sarasota Film Festival. "I just don't think that they're the dominant form anymore." Like he was once ...